#pharmaceutical-supply-chain
(11 articles)Pharma Supply Chain Faces Global Disruption: BCG-Dentons 2026
Boston Consulting Group and Dentons have jointly released an in-depth analysis examining structural vulnerabilities and emerging disruptions across the global pharmaceutical and life sciences supply c
Pharma Supply Chains Face Critical Vulnerabilities Amid Iran Tensions
The NATO Association analysis reveals that global pharmaceutical supply chains harbor significant structural vulnerabilities that geopolitical conflicts—particularly tensions with Iran—can rapidly exp
Trump's 2028 Generic Drug Tariff Proposal: Supply Chain Implications
The Trump administration's proposed tariff on generic drugs targeting 2028 represents a significant policy shift that could reshape pharmaceutical supply chains and pricing dynamics. While framed as a
Pharma Supply Chains: Beyond Price to Resilience Metrics
The pharmaceutical industry is undergoing a fundamental shift in how supply chains are evaluated and managed. Rather than optimizing solely for procurement costs, leading pharma companies are adopting
Trump's Generic Drug Tariffs Threaten Medicine Prices and Supply
The Trump administration's proposal to impose tariffs on generic drugs represents a significant structural shift in how the US pharmaceutical supply chain operates. Generic drugs, which represent roug
Air Cargo Delays Put Patient Treatment at Risk
Air cargo delays have escalated beyond operational inconvenience to become a patient safety and healthcare delivery issue. When pharmaceutical shipments, medical devices, and temperature-sensitive tre
Iran Conflict Threatens Global Pharmaceutical Supply Chains
A conflict involving Iran poses significant risk to global pharmaceutical supply chains due to the region's strategic importance in drug manufacturing and trade routes. Iran and neighboring countries
100 Essential US Medicines Face Hidden Supply Chain Risks
A comprehensive CIDRAP analysis has identified hidden supply chain vulnerabilities affecting approximately 100 essential medicines in the United States. These risks stem from single-source dependencie
US Launches Section 301 Probe Into German Drug Pricing
The U.S. Trade Representative has initiated a Section 301 investigation into Germany's drug pricing policies, alleging that the European nation's regulatory framework unfairly shifts pharmaceutical re
Antwerp-Bruges joins Pharma.Aero, expanding pharma air logistics
The Port of Antwerp-Bruges has achieved a significant milestone by becoming the first seaport to join Pharma.Aero, an aviation industry network focused on improving pharmaceutical supply chain efficie
Airfreight Industry Unprepared for Pharma Surge, DSV Expands
The air cargo industry faces a critical readiness challenge as demand for temperature-sensitive pharmaceutical shipments accelerates. DSV's expansion of its Air ThermoDirect service with a new Luxembo